In this study, with a median follow-up of 25 months, the primary composite end point including cardiovascular death, MI, stroke, and hospitalization for unstable angina occurred in 406 patients (13.4%) in the lixisenatide group and in 399 (13.2%) in the placebo group (HR, 1.02
People with diabetes are more likely than the general population to have depression and anxiety
Appetite-suppressing GLP-1 inhibitors like Ozempic and Mounjaro have grabbed headlines for their efficacy in helping people who are overweight or obese shed pounds
doi: 10.1186/s13052-020-0798-4 126 MarchantJ
12 As to whether GLP-1 drugs were associated with changes in DME, there is still not yet enough conclusive evidence
It neutralizes the free radicals in the body